DOCSLIB.ORG

Simple Continuous and Simultaneous Determination of Multiple Sulfonamide Residues

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Simple Continuous and Simultaneous Determination of Multiple Sulfonamide Residues 1067 Journal of Food Protection, Vol. 56, No. 12, Pages 1067-1072 (December 1993) Copyright©, International Association of Milk, Food and Environmental Sanitarians Simple Continuous and Simultaneous Determination of Multiple Sulfonamide Residues CHIN-EN TSAI and FUSAO KONDO* Department of Veterinary Public Health, Faculty of Agriculture, Miyazaki University, Kibanadai-Nishi, Gakuen, Miyazaki-shi 889-21, Japan Downloaded from http://meridian.allenpress.com/jfp/article-pdf/56/12/1067/1659673/0362-028x-56_12_1067.pdf by guest on 30 September 2021 (Received for publication September 14, 1992) ABSTRACT trimethoprim (TMP) has been used as a test medium for sulfonamides. Sulfonamides and TMP inhibit the enzymes A new continuous separation method was developed for the of the tetrahydrofolate biosynthetic pathway in two sequen­ determination of nine different sulfonamides (sulfaguanidine, sulfamethazine, sulfapyridine, sulfadiazine, sulfathiazole, tial steps and have a synergistic effect which has been used sulfamethizole, sulfamethoxazole, sulfadimethoxine, and for therapeutic purposes for some years (7). For extraction, sulfaquinoxaline). Bioassay on minimum medium seeded with the cleanup method is complicated, involving Bacillus subtilis ATCC 6633 was carried out for detection. An deproteinization and removal of fatty acids from biological extract taken from an agar block of the clear inhibition zone on materials that are shown to be residual positive by bioassay. minimum medium produced by a mixture of sulfonamides was This has usually been done in accordance with each anti­ then subjected to high-performance liquid chromatography. bacterial agent tested, and much time is needed to obtain For identification, high-performance liquid chromatography the test sample for identification (3,8). As MM does not analyses were performed using two different columns and analyti­ contain any peptone, the cleanup method for extraction cal conditions. Using a u-Bondapak C column, the sulfonamides 18 would therefore be comparatively easy. were separated at room temperature using a mobile phase of methanol: 0.1 M KH2P04 (30:70, vol/vol) at a flow rate of 1.0 ml/ HPLC is becoming increasingly popular for the identi­ min. A variable wavelength detector set at 265 nm and recorder fication of chemical substances, and there are many reports set at 4 mm/min were used for the detection. The entire mixture on the identification of single sulfonamides (1-6,9,10,17) was resolved as eight peaks from 4.68 to 50.78 min. When an by HPLC analysis. Recently, however, more reports have Asahipak GS-320 column was employed, nine peaks were sepa­ appeared describing the simultaneous determination and rated with retention times ranging from 12.62 to 54.43 min using identification of multiple sulfonamides in animal tissues a mobile phase of acetonitrile: 1% acetic acid (25:75, vol/vol) at (8,11,16), animal feed (12,15), and food products (13) a flow rate of 2.0 ml/min. using HPLC. Generally, however, it has proved difficult to Correlation coefficients of standard curves for individual separate a large number of drugs in test samples by HPLC sulfonamides were linear (>0.99) with recoveries ranging from analysis. 25.2 ± 8.6% to 64.1 ± 8.6% for a concentration range of 1.0-25 lig/ml. Many analysts use a reverse-phase column for elution by the gel-permeation chromatography mode in sulfona­ Sulfonamides are widely used as antimicrobial agents mide determination by HPLC (1,4-6,12). It is difficult to and growth promoters in veterinary practice and animal clearly separate the early eluting drug peaks from protein production. The safety of these drugs for consumers has peaks originating from the biological samples themselves been questioned because of their apparent toxicity (9). in the reverse-phase column. Therefore, a sensitive and reliable method is needed for However, a new Asahipak GS-320 column has been monitoring of sulfonamide residues. developed recently by Asahi Kasei Co., Ltd., Tokyo, Japan. In general, the inspection of residual antimicrobial This column has characteristics suitable for rapid separa­ agents in meat is performed according to the following tion of relatively hydrophilic high-molecular-weight com­ steps: i) detection by microbiological assay, ii) extraction pounds, including most proteins, nucleosides, and glycans, (cleanup) from the residual-positive tissue, and iii) identifi­ by gel permeation. Low-molecular-weight hydrophobic com­ cation by high-performance liquid chromatography (HPLC). pounds are eluted slowly. Thus, gel-permeation chromatog­ In microbiological screening, Mueller-Hinton agar raphy can separate drugs and their metabolites, and with (MHA, Difco) and antibiotic medium No. 5 (Difco) have this column, it is possible to use incompletely deproteinized often been used as assay media. These media contain some biological samples. peptone for the growth of test organisms. Minimum me­ In the present study, a new separation method was dium (MM), which does not contain peptone, was devel­ tested for determination of nine different sulfonamides. oped by Spizizen (14) for biochemical research on the MM seeded with B. subtilis ATCC 6633 was used for DNA of Bacillus subtilis. Also, MHA containing detection, followed by extraction from the clear area of JOURNAL OF FOOD PROTECTION, VOL. 56, DECEMBER 1993 1068 TSAI AND KONDO inhibition on the agar produced by mixed sulfonamides, Quantitation of sulfonamides was based on the linear rela­ and identification of the extract by HPLC. For the HPLC tionship between the peak heights (uV) in the chromatograms and analysis, we compared a reverse-phase |i-Bondapak C the known concentration (ug/ml) of the drugs. column and an Asahipak GS-320 column for simultaneous Preparation of agar taken from the inhibition zone on the agar determination of sulfonamides. plate Each concentration of the mixed sulfonamide solution, 1.0, MATERIALS AND METHODS 2.5, 5.0, 10.0, or 25.0 ug/ml, was used in the formation of an Chemicals used inhibition zone on MM without TMP. The agar surrounding the A total of nine sulfonamides were used in this study: paper disc on the MM plates was transferred into an injection sulfaguanidine (SGN), sulfamethazine (SMT), sulfapyridine (SPR), syringe using a small spoon or knife. The plunger of the syringe sulfadiazine (SDZ), sulfathiazole (STZ), sulfamethizole (SMI), was pushed by hand, and the agar was broken into pieces by sulfamethoxazole (SMX), sulfadimethoxine (SDM), and passage through the syringe needle. The broken agar was trans­ sulfaquinoxaline (SQ). All except STZ were purchased from ferred immediately to a centrifuge tube, then 2.0 ml of ethyl Sigma Chemical Co., St. Louis, MO. STZ was purchased from acetate (Wako Pure Chemical Industries, Ltd., Osaka, Japan) was Tokyo Kasei Kogyo Co., Tokyo, Japan. Each sulfonamide, except added to the tube for extraction, followed by centrifugation at Downloaded from http://meridian.allenpress.com/jfp/article-pdf/56/12/1067/1659673/0362-028x-56_12_1067.pdf by guest on 30 September 2021 SDM, was first dissolved in N.N-dimethylformamide at 10% 1,000 x g for 5 min. The supernatant was evaporated to dryness wt/vol. SDM was dissolved in 28% ammonia to a final concentra­ in a 40°C water bath under nitrogen gas. The sediment was tion of 10% wt/vol. These stock solutions were further diluted to suspended in 0.08 ml of a mobile phase of acetonitrile: 1% acetic a concentration of 1,000 Ug/ml. SPR and SDZ were diluted in acid (25:75, vol/vol) and then centrifuged at 7,000 x g for 6 min. 0.05 M NaH2P04 buffer (pH 7.0). The other seven sulfonamides Fifty microliters of the supernatant was injected into the HPLC. A were diluted to 1,000 ug/ml with distilled water. These solutions schematic representation of the procedure for extraction from the are referred to as working solutions. The working solutions were agar within the clear inhibition zone for each antibacterial agent diluted in twofold serial dilutions from 100 to 0.05 ug/ml in water on MM is shown in Fig. 1. The extraction time was less than 30 for the bioassay or in the mobile phase for HPLC analysis. The min. mixture of nine sulfonamides was prepared by adding together 1 ml of each working solution. Recovery The recoveries from the agar were determined by HPLC Disc diffusion method analysis using a GS-320 column with six replicates. The recover­ Trimethoprim (TMP, Nakarai Tesque Co., Kyoto, Japan) was ies of each sulfonamide from the agar were determined by used for examining any synergistic effect in the sulfonamides comparing the peak heights obtained by chromatography with bioassay (11). those of pure drug standards. Eight milliliters of MM or MHA seeded with B. subtilis ATCC 6633 was poured into a disposable, sterilized petri dish (90 mm diameter) to a thickness of 2 mm. The media were compared with or without TMP (final concentration 0.05 (ig/ml). Hinimum nediura seeded with B. subtilis ATCC-6633 (spore) All drugs were tested at a concentration of 100 ug/ml and in Incubate'Yor 18 h, at 37°C twofold serial dilutions to 0.05 ug/ml in sterile distilled water. A • Paper disc filter paper disc (type 27, 10 mm diameter, Toyo Roshi Co., Ltd.) was moistened with 0.08 ml of the drug solution and put on the " Inhibition zone surface of the plate. The plates were incubated at 37°C for 18 h, and the diameter of the clear inhibition zone surrounding the paper disc was measured. The lowest concentration which com­ pletely inhibited growth of the test organism was recorded for Agar block • each antibacterial agent. HPLC analysis (i) Apparatus. The apparatus consisted of a Model 600E [Extraction method] multisolvent delivery system, a U6K injection system, a Model Syringe for breaking up agar 481 variable-wavelength detector (Waters Associates, Inc., Milford, MA), and a chromatopac C-R6A (Shimadzu Seisaku Co., Ltd., Kyoto, Japan) used as an integrator.
Load more

Recommended publications
  • Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications
    International Journal of Molecular Sciences Review Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications Daniel Fernández-Villa 1, Maria Rosa Aguilar 1,2 and Luis Rojo 1,2,* 1 Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain; [email protected] (D.F.-V.); [email protected] (M.R.A.) 2 Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, 28029 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-915-622-900 Received: 18 September 2019; Accepted: 7 October 2019; Published: 9 October 2019 Abstract: Bacterial, protozoan and other microbial infections share an accelerated metabolic rate. In order to ensure a proper functioning of cell replication and proteins and nucleic acids synthesis processes, folate metabolism rate is also increased in these cases. For this reason, folic acid antagonists have been used since their discovery to treat different kinds of microbial infections, taking advantage of this metabolic difference when compared with human cells. However, resistances to these compounds have emerged since then and only combined therapies are currently used in clinic. In addition, some of these compounds have been found to have an immunomodulatory behavior that allows clinicians using them as anti-inflammatory or immunosuppressive drugs. Therefore, the aim of this review is to provide an updated state-of-the-art on the use of antifolates as antibacterial and immunomodulating agents in the clinical setting, as well as to present their action mechanisms and currently investigated biomedical applications. Keywords: folic acid antagonists; antifolates; antibiotics; antibacterials; immunomodulation; sulfonamides; antimalarial 1.
    [Show full text]
  • The Local Use of the Sulfonamide Drugs
    THE LOCAL USE OF THE SULFONAMIDE DRUGS GEORGE CRILE Jr., M.D. Since the introduction of sulfanilamide and its derivatives, the reliance upon chemotherapy for the control of acute surgical infections has temporarily overshadowed the importance of sound surgical princi- ples and often has resulted in the administration of inefficient or inade- quate treatment. Too often, the physician fails to recognize the limita- tions of chemotherapy and vainly attempts to control the infection well beyond the optimum time for surgical intervention. Chemotherapy is very effective in controlling infections from hemo- lytic streptococcus; is moderately effective in controlling staphylococcic infections; but is of slight value when administered systemically in patients infected with the nonhemolytic streptococcus or colon bacillus. However, even in infections caused by the hemolytic streptococcus or the staphylococcus, sulfanilamide and sulfathiazole cannot replace surgery after suppuration has taken place and mechanical drainage of an abscess is required. It is in the treatment of lymphangitis and cellulitis, not in the treatment of abscesses, that chemotherapy has been of the greatest value. The work of Lockwood1 and others has indicated that the products of proteolysis in vitro interfere with the bacteriostatic and bacteriocidal powers of sulfanilamide. The presence of similar substances in undrained abscess cavities probably interferes with the destruction of the organ- isms by chemotherapy. Accordingly, the sulfonamide drugs should supplement rather than replace early and adequate surgical drainage, especially in the presence of suppuration. The local application of the sulfonamide drugs is based upon the principle that the local concentration of the drug in the tissues is ten to twenty times as high as that which can be obtained by any method of systemic administration.
    [Show full text]
  • Milk and Dairy Beef Drug Residue Prevention
    Milk and Dairy Beef Drug Residue Prevention Producer Manual of Best Management Practices 2014 Connecting Cows, Cooperatives, Capitol Hill, and Consumers www.nmpf.org email: [email protected] National Milk Producers Federation (“NMPF”) does not endorse any of the veterinary drugs or tests identified on the lists in this manual. The lists of veterinary drugs and tests are provided only to inform producers what products may be available, and the producer is responsible for determining whether to use any of the veterinary drugs or tests. All information regarding the veterinary drugs or tests was obtained from the products’ manufacturers or sponsors, and NMPF has made no further attempt to validate or corroborate any of that information. NMPF urges producers to consult with their veterinarians before using any veterinary drug or test, including any of the products identified on the lists in this manual. In the event that there might be any injury, damage, loss or penalty that results from the use of these products, the manufacturer of the product, or the producer using the product, shall be responsible. NMPF is not responsible for, and shall have no liability for, any injury, damage, loss or penalty. ©2014 National Milk Producers Federation Cover photo courtesy of DMI FOREWORD The goal of our nation’s dairy farmers is to produce the best tasting and most wholesome milk possible. Our consumers demand the best from us and we meet the needs of our consumers every day. Day in and day out, we provide the best in animal husbandry and animal care practices for our animals.
    [Show full text]
  • Multi-Residual Quantitative Analytical Method for Antibiotics in Sea Food by LC/MS/MS
    PO-CON1742E Multi-residual quantitative analytical method for antibiotics in sea food by LC/MS/MS ASMS 2017 TP 198 Anant Lohar, Shailendra Rane, Ashutosh Shelar, Shailesh Damale, Rashi Kochhar, Purushottam Sutar, Deepti Bhandarkar, Ajit Datar, Pratap Rasam and Jitendra Kelkar Shimadzu Analytical (India) Pvt. Ltd., 1 A/B, Rushabh Chambers, Makwana Road, Marol, Andheri (E), Mumbai-400059, Maharashtra, India. Multi-residual quantitative analytical method for antibiotics in sea food by LC/MS/MS Introduction Antibiotics are widely used in agriculture as growth LC/MS/MS method has been developed for quantitation of enhancers, disease treatment and control in animal feeding multi-residual antibiotics (Table 1) from sea food sample operations. Concerns for increased antibiotic resistance of using LCMS-8040, a triple quadrupole mass spectrometer microorganisms have prompted research into the from Shimadzu Corporation, Japan. Simultaneous analysis environmental occurrence of these compounds. of multi-residual antibiotics often exhibit peak shape Assessment of the environmental occurrence of antibiotics distortion owing to their different chemical nature. To depends on development of sensitive and selective overcome this, autosampler pre-treatment feature was analytical methods based on new instrumental used [1]. technologies. Table 1. List of antibiotics Sr.No. Name of group Name of compound Number of compounds Flumequine, Oxolinic Acid, Ciprofloxacin, Danofloxacin, Difloxacin.HCl, 1 Fluoroquinolones 8 Enrofloxacin, Sarafloxacin HCl Trihydrate,
    [Show full text]
  • (OTC) Antibiotics in the European Union and Norway, 2012
    Perspective Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012 L Both 1 , R Botgros 2 , M Cavaleri 2 1. Public Health England (PHE), London, United Kingdom 2. Anti-infectives and Vaccines Office, European Medicines Agency (EMA), London, United Kingdom Correspondence: Marco Cavaleri ([email protected]) Citation style for this article: Both L, Botgros R, Cavaleri M. Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012. Euro Surveill. 2015;20(34):pii=30002. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.34.30002 Article submitted on 16 September 2014 / accepted on 09 February 2015 / published on 27 August 2015 Antimicrobial resistance is recognised as a growing throughout the EU; however, there are still consider- problem that seriously threatens public health and able differences in Europe due to the different health- requires prompt action. Concerns have therefore been care structures and policies (including the extent of raised about the potential harmful effects of making pharmacist supervision for OTC medicines), reimburse- antibiotics available without prescription. Because of ment policies, and cultural differences of each Member the very serious concerns regarding further spread of State. Therefore, the availability of OTC medicines var- resistance, the over-the-counter (OTC) availability of ies in the EU and products sold as POM in certain coun- antibiotics was analysed here. Topical and systemic tries can be obtained as OTC medicines in others. OTC antibiotics and their indications were determined across 26 European Union (EU) countries and Norway As risk minimisation is an important criterion for some by means of a European survey.
    [Show full text]
  • Applications
    APPLICATIONS Zeshan Aqeel Senior Application Scientist A Screen of 22 Common Antibiotics that Demonstrates Zeshan loves to collect watches and the Back to the the Unique Reversed Phase Selectivity and Improved Future Trilogy. He has twin boys who drive him crazy! He Chromatographic Performance for Bases using a is an Apple Fanboy for life and ® he likes being in the lab more Kinetex PS C18 HPLC/UHPLC Column than anywhere else. Zeshan Aqeel, Jeff Layne, and Ryan Splitstone Phenomenex, Inc., 411 Madrid Ave, Torrance CA 90501 USA Overview Ciprofloxacin The Kinetex PS C18 is a USP classified L1 column, that provides Molecular Formula: C17H19FN3O3 both a unique polar/hydrophobic selectivity, and is 100 % aqueous Basic pKa: 8.77 stable. The column demonstrates enhanced selectivity and peak Acidic pKa: 5.56 shape for basic compounds under typical reversed phase condi- LogP: -0.86 tions. In addition, the solid support is a Kinetex core-shell (superfi- CH3 cially porous) particle morphology that provides ultra-high column + O S O 1 NH efficiency on any HPLC or UHPLC system. CH3 2 N N + O S O The mobile phase program chosen was a routine gradientNH of Acetonitrile with 0.1 % Formic Acid as the strong organic solvent2 and Water with 0.1 % Formic Acid as Nthe weak solvent.N The flow O F rate of 0.5 mL/min was used, and the column heater was set to ambient temperature (25 °C).O OH O F F OH Introduction OH O HO N In this application, 22 antibiotics were analyzed to demonstrate the F OH Kinetex PS C18 HPLC/UHPLC column’s unique multi-modal selec- F tivity and improved chromatographic performance for polar bases.
    [Show full text]
  • Sulfonamides and Sulfonamide Combinations*
    Sulfonamides and Sulfonamide Combinations* Overview Due to low cost and relative efficacy against many common bacterial infections, sulfonamides and sulfonamide combinations with diaminopyrimidines are some of the most common antibacterial agents utilized in veterinary medicine. The sulfonamides are derived from sulfanilamide. These chemicals are structural analogues of ρ-aminobenzoic acid (PABA). All sulfonamides are characterized by the same chemical nucleus. Functional groups are added to the amino group or substitutions made on the amino group to facilitate varying chemical, physical and pharmacologic properties and antibacterial spectra. Most sulfonamides are too alkaline for routine parenteral use. Therefore the drug is most commonly administered orally except in life threatening systemic infections. However, sulfonamide preparations can be administered orally, intramuscularly, intravenously, intraperitoneally, intrauterally and topically. Sulfonamides are effective against Gram-positive and Gram-negative bacteria. Some protozoa, such as coccidians, Toxoplasma species and plasmodia, are generally sensitive. Chlamydia, Nocardia and Actinomyces species are also sensitive. Veterinary diseases commonly treated by sulfonamides are actinobacillosis, coccidioidosis, mastitis, metritis, colibacillosis, pododermatitis, polyarthritis, respiratory infections and toxo- plasmosis. Strains of rickettsiae, Pseudomonas, Klebsiella, Proteus, Clostridium and Leptospira species are often highly resistant. Sulfonamides are bacteriostatic antimicrobials
    [Show full text]
  • A Rapid Multi-Residue Method for the Determination of Sulfonamide And
    A RAPID MULTIRESIDUE METHOD FOR THE DETERMINATION OF SULFONAMIDE AND ß-LACTAM RESIDUES IN BOVINE MILK Gordon Kearney NOTE Waters Corporation, Manchester, UK Introduction Method Various sulfonamide and ß-lactam antibacterial Three recovery samples at 4 ppb and three at compounds may be used to treat disease in lactating 40 ppb were prepared. Matrix matched external dairy cattle and it is therefore necessary to monitor calibration standards were prepared at 0, 1, 10, 20, milk for the presence of residues of these drugs. In 50 and 100 ppb. Since 1 mL milk is equivalent to the European Union, maximum residue level (MRL) 0.5 mL final extract, a concentration of 1 ppb residue values range from 100 ppb, as a total concentration in milk is equivalent to a concentration of 2 ng/mL in of all sulfonamides, to 4 ppb for each of the penicillin the final extract. compounds amoxillin and ampicillin[1]. In the USA, Extraction the tolerance levels are 10 ppb for both these penicillin compounds, but the use of most sulfonamides 1 mL aliquots of pasteurized, homogenized cows [2] Application is prohibited in cattle used for milk production . milk, containing 4% fat, were transferred to 2 mL polypropylene sample tubes. Recovery samples Multiresidue analyses are increasingly gaining were spiked, agitated and left to equilibrate for acceptance for the determination of residues in 30 minutes. In order to separate the lipid from the foodstuffs; methods have recently been published for aqueous portion, the tubes were centrifuged at the monitoring of over 150 pesticide compounds in 13,000 rpm for 10 minutes.
    [Show full text]
  • Third ESVAC Report
    Sales of veterinary antimicrobial agents in 25 EU/EEA countries in 2011 Third ESVAC report An agency of the European Union The mission of the European Medicines Agency is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health. Legal role Guiding principles The European Medicines Agency is the European Union • We are strongly committed to public and animal (EU) body responsible for coordinating the existing health. scientific resources put at its disposal by Member States • We make independent recommendations based on for the evaluation, supervision and pharmacovigilance scientific evidence, using state-of-the-art knowledge of medicinal products. and expertise in our field. • We support research and innovation to stimulate the The Agency provides the Member States and the development of better medicines. institutions of the EU the best-possible scientific advice on any question relating to the evaluation of the quality, • We value the contribution of our partners and stake- safety and efficacy of medicinal products for human or holders to our work. veterinary use referred to it in accordance with the • We assure continual improvement of our processes provisions of EU legislation relating to medicinal prod- and procedures, in accordance with recognised quality ucts. standards. • We adhere to high standards of professional and Principal activities personal integrity. Working with the Member States and the European • We communicate in an open, transparent manner Commission as partners in a European medicines with all of our partners, stakeholders and colleagues. network, the European Medicines Agency: • We promote the well-being, motivation and ongoing professional development of every member of the • provides independent, science-based recommenda- Agency.
    [Show full text]
  • Danmap 2006.Pmd
    DANMAP 2006 DANMAP 2006 DANMAP 2006 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark Statens Serum Institut Danish Veterinary and Food Administration Danish Medicines Agency National Veterinary Institute, Technical University of Denmark National Food Institute, Technical University of Denmark Editors: Hanne-Dorthe Emborg Danish Zoonosis Centre National Food Institute, Technical University of Denmark Mørkhøj Bygade 19 Contents DK - 2860 Søborg Anette M. Hammerum National Center for Antimicrobials and Contributors to the 2006 Infection Control DANMAP Report 4 Statens Serum Institut Artillerivej 5 DK - 2300 Copenhagen Introduction 6 DANMAP board: National Food Institute, Acknowledgements 6 Technical University of Denmark: Ole E. Heuer Frank Aarestrup List of abbreviations 7 National Veterinary Institute, Tecnical University of Denmark: Sammendrag 9 Flemming Bager Danish Veterinary and Food Administration: Summary 12 Justin C. Ajufo Annette Cleveland Nielsen Statens Serum Institut: Demographic data 15 Dominique L. Monnet Niels Frimodt-Møller Anette M. Hammerum Antimicrobial consumption 17 Danish Medicines Agency: Consumption in animals 17 Jan Poulsen Consumption in humans 24 Layout: Susanne Carlsson Danish Zoonosis Centre Resistance in zoonotic bacteria 33 Printing: Schultz Grafisk A/S DANMAP 2006 - September 2007 Salmonella 33 ISSN 1600-2032 Campylobacter 43 Text and tables may be cited and reprinted only with reference to this report. Resistance in indicator bacteria 47 Reprints can be ordered from: Enterococci 47 National Food Institute Escherichia coli 58 Danish Zoonosis Centre Tecnical University of Denmark Mørkhøj Bygade 19 DK - 2860 Søborg Resistance in bacteria from Phone: +45 7234 - 7084 diagnostic submissions 65 Fax: +45 7234 - 7028 E.
    [Show full text]
  • Pharmaceuticals As Environmental Contaminants
    PharmaceuticalsPharmaceuticals asas EnvironmentalEnvironmental Contaminants:Contaminants: anan OverviewOverview ofof thethe ScienceScience Christian G. Daughton, Ph.D. Chief, Environmental Chemistry Branch Environmental Sciences Division National Exposure Research Laboratory Office of Research and Development Environmental Protection Agency Las Vegas, Nevada 89119 [email protected] Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Why and how do drugs contaminate the environment? What might it all mean? How do we prevent it? Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada This talk presents only a cursory overview of some of the many science issues surrounding the topic of pharmaceuticals as environmental contaminants Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada A Clarification We sometimes loosely (but incorrectly) refer to drugs, medicines, medications, or pharmaceuticals as being the substances that contaminant the environment. The actual environmental contaminants, however, are the active pharmaceutical ingredients – APIs. These terms are all often used interchangeably Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Office of Research and Development Available: http://www.epa.gov/nerlesd1/chemistry/pharma/image/drawing.pdfNational
    [Show full text]
  • Effects of Chlortetracycline and Copper Supplementation on Levels of Antimicrobial Resistance in the Feces of Weaned Pigs
    EFFECTS OF CHLORTETRACYCLINE AND COPPER SUPPLEMENTATION ON LEVELS OF ANTIMICROBIAL RESISTANCE IN THE FECES OF WEANED PIGS by GETAHUN EJETA AGGA DVM, Addis Ababa University, 2003 MSc, Utrecht University, 2008 AN ABSTRACT OF A DISSERTATION submitted in partial fulfillment of the requirements for the degree DOCTOR OF PHILOSOPHY Department of Diagnostic Medicine/Pathobiology College of Veterinary Medicine KANSAS STATE UNIVERSITY Manhattan, Kansas 2013 Abstract The use of antibiotics in food animals is of major concern as a purported cause of antimicrobial resistance (AMR) in human pathogens; as a result, alternatives to in-feed antibiotics such as heavy metals have been proposed. The effect of copper and CTC supplementation in weaned pigs on AMR in the gut microbiota was evaluated. Four treatment groups: control, copper, chlortetracycline (CTC), and copper plus CTC were randomly allocated to 32 pens with five pigs per pen. Fecal samples (n = 576) were collected weekly from three pigs per pen over six weeks and two Escherichia coli isolates per sample were tested phenotypically for antimicrobial and copper susceptibilities and genotypically for the presence of tetracycline (tet), copper (pcoD) and ceftiofur (blaCMY-2) resistance genes. CTC-supplementation significantly increased tetracycline resistance and susceptibility to copper when compared with the control group. Copper supplementation decreased resistance to most of the antibiotics, including cephalosporins, over all treatment periods. However, copper supplementation did not affect minimum inhibitory concentrations of copper or detection of pcoD. While tetA and blaCMY-2 genes were associated with a higher multi-drug resistance (MDR), tetB and pcoD were associated with lower MDR. Supplementations of CTC or copper alone were associated with increased tetB prevalence; however, their combination was paradoxically associated with reduced prevalence.
    [Show full text]